EBS
Emergent BioSolu (EBS)
NYSE
$5.99-$0.05 (-0.76%)
Price as of Nov 12, 2026 8:07 AM EST
  • $310.5M
    Market Cap
  • -44.13%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 39
Valuation
EBS
vs History
vs S&P 500
Profitability
-1
Growth
-1
Low Earnings Volatility
0

Momentum Score

Score: 26
Valuation
EBS
vs History
vs S&P 500
3-Month Momentum
55.28%
12-Month Momentum
-36.49%
3-Month Risk Adjusted Momentum
211.36%
12-Month Risk Adjusted Momentum
-54.74%

True Yield

N/A
Valuation
EBS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
4.91%
Net Debt Paydown Yield
15.81%

Financial Health Score

Score: 31
Valuation
EBS
vs History
vs S&P 500
Ohlson's O-Score
4